🔎 Trials Near Me

Akèy › Karsinom epatoseililè fibrolamèlè › Maryland

Etid klinik pou Karsinom epatoseililè fibrolamèlè nan Maryland

3 etid pou Karsinom epatoseililè fibrolamèlè ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

  • Johns Hopkins SKCCC, Baltimore
Ap rekriteFaz 1
Laj 12 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07430202

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

  • Johns Hopkins SKCCC, Baltimore
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT06027086

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

  • Sidney Kimmel Comprehensive Cancer Center, Baltimore
Ap rekriteFaz 1
Laj 12 ak plis · Tout sèks · Mizajou Dec 3, 2025 · NCT04248569

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.